Assignee
ACTAVIS GROUP PTC EHF
IS·4 granted patents·35 pending applications·3 citations·filing 2008–2015
Top patents by PatentIndex Score
39 records- 0175US7947699B2Anhydrous amorphous imatinib mesylateACTAVIS GROUP PTC EHF·Filed 2009·Granted May 24, 2011·3 cites·20 claims
- 0260US2009192228A1Controlled-Release Tolterodine Compositions and MethodsACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 0356US9006443B2Process for preparing quinoline-3-carboxamide derivativesACTAVIS GROUP PTC EHF·Filed 2013·Granted Apr 14, 2015·0 cites·20 claims
- 0456US2011117200A1Rasagiline mesylate particles and process for the preparation thereofACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 0554US9512060B2Solid state forms of tapentadol saltsACTAVIS GROUP PTC EHF·Filed 2015·Granted Dec 6, 2016·0 cites·12 claims
- 0653US2014323727A1Novel process for preparing phenylcyclopropylamine derivatives using novel intermediatesACTAVIS GROUP PTC EHF·Filed 2014·Application pending·0 cites
- 0753US2010152268A1Stable atorvastatin formulationsACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 0852US2014350301A1Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelorACTAVIS GROUP PTC EHF·Filed 2014·Application pending·0 cites
- 0950US2013072682A1Process for preparing varenicline, varenicline intermediates, and pharmaceutically acceptable salts thereofACTAVIS GROUP PTC EHF·Filed 2012·Application pending·0 cites
- 1049US8354428B2Solid state forms of laquinimod and its sodium saltACTAVIS GROUP PTC EHF·Filed 2009·Granted Jan 15, 2013·0 cites·18 claims
- 1148US2011021547A1Substantially Pure and a Stable Crystalline Form of BosentanACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 1247US2010260851A1Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin CalciumACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 1347US2011014291A1Novel Polymorphs of BosentanACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 1447US2010197732A1Repaglinide Substantially Free of Dimer ImpurityACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 1546US2011223213A1Highly pure ranolazine or a pharmaceutically acceptable salt thereofACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 1646US2010285075A1Novel Hemioxalate Salt of EletriptanACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 1746US2011171138A1Substantially pure deferasirox and processes for the preparation thereofACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 1846US2010204296A1Novel Polymorphs of Darifenacin Free Base and its Hydrobromide SaltACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 1944US2010104649A1Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl AcetoacetateACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 2044US2011178326A1Unsaturated cinacalcet salts and processes for preparing cinacalcet hydrochlorideACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 2144US2011142883A1Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable SaltsACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 2243US2009246284A1O-desmethylvenlafaxine CocrystalsACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 2343US2010297241A1Amorphous Fesoterodine FumarateACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 2442US2011097413A1Solid state forms of deferasirox salts and process for the preparation thereofACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 2542US2011046231A1Solid forms of (±)-o-desmethylvenlafaxine saltsACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 2642US2011171274A1Fesoterodine Substantially Free of Dehydroxy ImpurityACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 2740US2011086103A1Novel mandelate salt of fesoterodineACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 2840US2010174073A1Process for the preparation of alfuzosin and salts thereofACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 2939US2011245536A1Process for preparing pregabalinACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 3038US2015329546A1Novel crystalline form of ticagrelor and process for the preparation thereofACTAVIS GROUP PTC EHF·Filed 2012·Application pending·0 cites
- 3138US2011014246A1Amorphous arformoterol l-(+)-tartrateACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 3236US2009061005A1Paliperidone PolymorphsACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 3336US2010317859A1Process for the Preparation of Risedronate SodiumACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 3436US2010217034A1Process for the Preparation of FesoterodineACTAVIS GROUP PTC EHF·Filed 2008·Application pending·0 cites
- 3534US2009247553A1Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto ImpurityACTAVIS GROUP PTC EHF·Filed 2009·Application pending·0 cites
- 3633US2016051679A1Pemetrexed FormulationACTAVIS GROUP PTC EHF·Filed 2014·Application pending·0 cites
- 3730US2010330130A1Substantially pure imatinib or a pharmaceutically acceptable salt thereofACTAVIS GROUP PTC EHF·Filed 2010·Application pending·0 cites
- 3829US2010272815A1Amorphous form of tapentadol hydrochlorideACTAVIS GROUP PTC EHF·Filed 2010·Application pending·0 cites
- 3925US2011124903A1Solid state forms of fesoterodine intermediatesACTAVIS GROUP PTC EHF·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ACTAVIS GROUP PTC EHF files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →